Literature DB >> 6447163

Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.

J F Delfraissy, P Segond, P Galanaud, C Wallon, P Massias, J Dormont.   

Abstract

The in vitro antibody response of peripheral blood lymphocytes (PBL) from 19 patients with untreated systemic lupus erythematosus (SLE) was compared with that of 20 control patients and 44 normal subjects. Trinitrophenyl polyacrylamide beads (TNP-PAA) were used to induce IgM anti-TNP plaque-forming cells. SLE patients displayed a markedly depressed, and in most instances virtually absent, response. This was not due to an unusual kinetics of the response; nor could it be induced by preincubation of SLE patients' PBL. In co-cultures of SLE patients and normal PBL, the former, with few exceptions, did not exert a suppressive effect. In four patients the anti-TNP response of either unfractionated or T-depleted SLE PBL could be restored by T cells from a normal individual. Conversely in three of these patients, SLE T cells could not support the response of normal B cells, suggesting a T helper cell defect in SLE PBL. Concanavalin A (Con A)-induced suppressor cells of the antibody response could be assayed by two approaches: (a) in responder SLE patients, by the direct addition of Con A to TNP-PAA-stimulated cultures; (b) in seven patients by transfer of Con A-activated cells to the responding culture of a normal allogeneic donor. In both cases SLE PBL were able to exert a suppressive effect to the same extent as normal PBL.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447163      PMCID: PMC371515          DOI: 10.1172/JCI109827

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Regulation of the immune response in autoimmune NZB/NZW F1 mice. I. The spontaneous generation of splenic suppressor cells.

Authors:  J C Roder; D A Bell; S K Singhal
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

Review 2.  Evaluation of T-cells and thymic serum factors in man using the rosette technique.

Authors:  J F Bach
Journal:  Transplant Rev       Date:  1973

3.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

4.  Primary in vitro antibody response from human peripheral blood lymphocytes.

Authors:  J F Delfraissy; P Galanaud; J Dormont; C Wallon
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE.

Authors:  D R Budman; E B Merchant; A D Steinberg; B Doft; M E Gershwin; E Lizzio; J P Reeves
Journal:  Arthritis Rheum       Date:  1977-04

6.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus.

Authors:  J Baum; M Ziff
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

8.  Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus.

Authors:  H E Jasin; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

9.  Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.

Authors:  D A Horwitz; M A Garrett; A H Craig
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

10.  Loss of suppressor T cells in adult NZB/NZW mice.

Authors:  R S Krakauer; T A Waldmann; W Strober
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  23 in total

1.  T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots.

Authors:  B N Pham; L Prin; D Gosset; P Y Hatron; B Devulder; A Capron; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.

Authors:  A Kitani; M Hara; T Hirose; K Norioka; M Harigai; W Hirose; K Suzuki; M Kawakami; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

Review 3.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

4.  Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.

Authors:  N Suzuki; T Sakane; E G Engleman
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Increased concanavalin A induced suppression in treated and untreated coeliac disease.

Authors:  C O'Farrelly; U McKeever; C Feighery; D G Weir
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

6.  Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.

Authors:  C Morimoto; E L Reinherz; J A Distaso; A D Steinberg; S F Schlossman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

7.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

8.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  Functional T cell subpopulations responsible for hyposecretion of IL-2 in patients with systemic lupus erythematosus.

Authors:  T Hayama; N Kubo; E Ikeda; H Hashimoto; S Sawada; T Horie
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

10.  Defective B cell function in systemic lupus erythematosus.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.